About us

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Since 2010, we invest in pioneering science that offers the potential to provide a significant benefit for our patients.

Since innovation is not restricted by geography, we invest worldwide.